MetaADEDB 2.0 @ LMMD
dolasetron
(PSGRLCOSIXJUAL-UMBGRREESA-N)
Structure
SMILES
CS(=O)(=O)O.O=C1CN2C3CC1C[C@H]2CC(C3)OC(=O)c1c[nH]c2c1cccc2
Molecular Formula:
C20H24N2O6S
Molecular Weight:
420.479
Log P:
3.0417
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
2
TPSA:
125.15
CAS Number(s):
115956-13-3
Synonym(s)
1.
dolasetron
2.
1H-indole-3-carboxylic acid, (6R,9AS)-octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, rel-, methanesulfonate, hydrate (1:1:1)
3.
1H-indole-3-carboxylic acid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, (2-alpha,6-alpha,8-alpha,9a-beta)-
4.
1H-indole-3-carboxylic acid-trans-octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester methanesulfonate
5.
Anzemet
6.
MDL 73,147EF
7.
MDL 73147EF
8.
MDL-73147EF
9.
dolasetron mesilate monohydrate
10.
dolasetron mesylate
11.
dolasetron mesylate monohydrate
12.
indole-3-carboxylic acid, ester with (8R)-hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one
13.
octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl 1H-indole-3-carboxylate
External Link(s)
MeSHC060344
PubChem Compound24839546
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1BradycardiaFAERS: 4US FAERS
2Cardiac ArrestFAERS: 2US FAERS
3Atrioventricular BlockFAERS: 1US FAERS
4Drug exposure during pregnancyFAERS: 1US FAERS
5Drug toxicityFAERS: 1US FAERS
6Facial NeuralgiaFAERS: 1US FAERS
7Myocardial InfarctionFAERS: 1US FAERS
8NauseaFAERS: 1US FAERS
9OculogyrationFAERS: 1US FAERS
10Oncologic complicationFAERS: 1US FAERS
11OpisthotonusFAERS: 1US FAERS
12Skin reactionFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.